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Abstract: Introduction: To report the prevalence of various prostate lesions in the general population through cadaver
prostates and to determine the interobserver variability for reporting high-grade lesions of the prostate. Materi-
als and Methods: The cross-sectional study was carried out on 110 autopsy specimens of healthy prostate with
deceased age over 40 years. The specimens were grossed, sectioned, stained and reported independently by
the primary investigator resident and the senior professor. The lesions were categorized into prostatitis, benign
prostate hypertrophy (BPH), prostate intraepithelial neoplasia (PIN) further graded as low grade (LGPIN) and
high grade (HGPIN) and prostate cancer (PCa). Inter-rater kappa agreement was used to find the strength of
agreement between the pathologists. Results: Among 110 prostate specimens, only 8(7.27%) cases had normal
prostate with 72 (65.4%) having BPH and 12(10.9%) cases having prostatitis. There were 17 cases of PIN with
11 cases of HGPIN and 6 cases of LGPIN. Malignancy was seen in only a single case (95% Confidence Interval:
0% - 2.71%). The primary resident missed 4 cases of HGPIN and 2 cases of LGPIN. Interobserver agreement
between the resident and senior pathologist was fair (Kappa 0.282, p value=0.335). Conclusion: In conclusion,
prostate lesions remain latent and show high prevalence in general population without causing any symptoms.
The study depicts a high interobserver variability of reporting the high-grade lesions of prostate since they cause
a diagnostic dilemma with PCa. The consultation with uropathologists and use of molecular markers must be
included in the diagnostic panel while reaching a final diagnosis.
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1. Introduction
Prostate cancer (PCa) is one of the most common malignancy
in males; second only to lung carcinoma. In 2018, there were
1,276,106 new cases with 3.8% cancer-related mortality(1, 2).
Studies propose the incidence of such conditions to double
by the end of 2030(3-5).
In India, the incidence rate of PCa was estimated at 3.9
per100,000 men, with 25,696 new cases and 9% cancer re-
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lated mortality(6). The vast majority of cases are adeno-
carcinoma with squamous cell, transitional cell, and small
cell carcinoma accounting for only a small minority of cases.
Racial differences have been found to occur in the prevalence
of prostatic carcinoma with the prevalence being higher
among African-Americans and lower among Asians(7).
The diagnosis of PCa involves the screening of men aged
40 years or more with serum prostate specific antigen (PSA)
levels and digital rectal examination (DRE). The procedure
may be followed by a biopsy for clearing a suspicion(8).
PSA carries a relatively low specificity (36%)(9) and on the
other hand, TRUS biopsy also misses 20–30% of patients with
PCa. Imaging techniques such as Multiparametric magnetic
resonance imaging (mp-MRI)(10) and Ultrasound elastogra-
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phy(11, 12) has shown a definite role in the definitive diagno-
sis but the gold standard still remains the biopsy(11).
High-grade prostatic intraepithelial neoplasia (HGPIN) is an
acceptable precursor to PCa but its recognition may require
a good expertise and correlation among two or more pathol-
ogists(13). The accurate diagnosis of PIN may depend on a
variety of factors including the specimen type, grossing, sec-
tions, tissue preparation and inconsistent reporting among
different pathologists(14). In prostate gland several lesions
with some of the histological features simulating adenocar-
cinoma have been described, but it has not been established
that any of these patterns represent biological precursor of
invasive carcinoma(15).
It is difficult to assess the malignant potential of the histolog-
ical abnormality in the solid organ like prostate as it is not
possible to follow clinically the evolution of questionable le-
sions found at biopsy. The original biopsy site cannot be lo-
cated subsequently with an accurate degree of precision, and
if carcinoma develops later the tumor is usually too large by
the time of its detection to allow determination of its exact
point of origin. Similarly, the organ cannot be sampled as re-
peatedly and early as can be done with organs like cervix.
It is probably because of these limitations, that the signifi-
cance of the pre-malignant state or intraepithelial neoplasm
in prostate was appreciated quite late. In spite of potential
significance of identification of pre-malignant phase in nat-
ural history of prostatic carcinoma, very little attention has
been given in detecting any such possibility by means of al-
ternate modalities.
This calls for a standard following of College of American
Pathologists (CAP) protocol for patients undergoing Prostate
biopsy(16). Also, it becomes pertinent to understand the
prevalence of various prostate lesions in different age groups
in general population for a rough prediction or the high grade
lesions of the prostate.
The present study was undertaken to report the prevalence
of various prostate lesions in the general population through
cadaver prostates and to determine the interobserver vari-
ability for reporting high grade lesions of the prostate.
2. Materials and Methods
A cross-sectional study was carried out in the medical in-
stitute attached to the government general hospital in Pune
over a period of 15 months. This study was approved by the
Institutional ethical committee. Since the cadaver was au-
topsied in the hospital, it was considered an applied con-
sent for the present study. No further consent was obtained
from the patient’s relatives for the study. The sample size cal-
culation of the study was based on the study of Aldaoud et
al.(13), who observed that prevalence of high-grade prostate
intraepithelial neoplasia was 34%. Taking this value as refer-
ence, the minimum required sample size with 9% margin of
error and 5% level of significance is 107patients. To reduce
margin of error, total sample size taken is 110. The 110 ca-
daver specimens were consecutively analysed for inclusion
in the study as per the eligibility criteria.
2.1. Inclusion criteria
Cadaver specimens of prostate, which underwent routine
full-body autopsy in the hospital; Age of Deceased 40 years
and above; Healthy prostate of the deceased.
2.2. Exclusion criteria
Any cadaver with previous or recent history of prostatic com-
plaints. All these specimens were processed in the surgi-
cal pathology and autopsy sections of the same institute.
The tissues were processed as routine procedures, that is, by
preparing paraffin blocks and taking 5-micron thick sections
with manual microtome. These sections were stained with
Haematoxylin and Eosin (H&E). After primary examination
of these tissues, few of them showing evidence of PIN were
treated with special stains like PAS. This was done to demon-
strate intact basal lamina in cases of high grade PIN. All spec-
imens of prostate were subjected to thorough gross exami-
nation. These specimens were fixed in 10% formalin before
submitting for processing. A total four sections at first trim-
ming were submitted for processing. These sections were
taken from different areas of the gland in an attempt to get
tissues from all zones of the entire prostate gland.
The trimmed tissues were kept in 10% formalin overnight
and then taken for further processing - i.e., dehydration with
ascending grades of alcohol embedding with paraffin and
cutting with microtome. The sections were cut at 5-micron
thickness and stained with Ehrlich’s hematoxylin and eosin
solution for primary reporting of the tissues.
The lesions were categorized into prostatitis, benign pro-
static hyperplasia (BPH), prostate intraepithelial neoplasia
(PIN) further graded as low grade (LGPIN) and high grade
(HGPIN) and PCa. The glands with evidence of HGPIN or
suspicious of malignancy were re-sectioned and multiple
sections were taken from different areas of the gland other
than the previously trimmed areas. This was done to find
out the possible foci of malignancy in the other parts of the
gland. The final reporting was blindly reviewed by two inde-
pendent pathologists (resident doctor and senior professor)
and labeled accordingly. Inter-rater kappa agreement was
used to find the strength of agreement between the patholo-
gists with the report of the senior professor being taken as the
final. BPH was defined by increase of glandular and stromal
tissue with papillary buds, infoldings and cysts. The basal
layer was continuous which differentiated it from PIN. PIN
was considered to be characterized by proliferation and dys-
plasia of cells lining prostatic ducts and acini with nuclear
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crowding, pleomorphism, nucleomegaly, presence of nucle-
oli, basal cell layer disruption, loss of polarity and stratifi-
cation(17, 18). It was divided into two grades, low grade
(grade-I) and high grade (Grade-II and Grade-III). Malignant
transformation was characterised by loss of basal cells, with
glands being(19) too many, too small, and too crowded.
2.3. Statistical analysis
The presentation of the Categorical variables was done in the
form of number and percentage (%). On the other hand, the
presentation of the continuous variables was done as mean ±
SD values. The association of the variables, which were quali-
tative in nature, were analysed using Chi-Square test/Fisher’s
exact test. Inter-rater kappa agreement was used to find the
strength of agreement between the pathologists.
The data entry was done in the Microsoft EXCEL spreadsheet
and the final analysis was done with the use of Statistical
Package for Social Sciences (SPSS) software ver 21.0.
For statistical significance, p value of less than 0.05 was con-
sidered as significant.
3. Results
A total of 110 prostate specimens of cadavers were included
in the study which were characterized by mean cadaver age
of 52.64 ± 8.32 years. The prevalence of various prostatic le-
sions has been shown in Table 1. It was interesting to note
that only 8(7.27%) cases had normal prostate (95% Confi-
dence Interval: 2.34% - 12.2%) with 72 (65.4%) having be-
nign prostate hypertrophy (95% Confidence Interval: 56%
- 73.9%) and 12(10.9%) cases having prostatitis (95% Confi-
dence Interval: 5% - 16.7%). There were 17 cases of PIN with
11 cases of HGPIN (95% Confidence Interval: 4.3% - 15.6%)
and 6 cases of LGPIN (95% Confidence Interval: 1.1% - 9.6%).
Malignancy was seen in only a single case (95% Confidence
Interval: 0% - 2.71%).
Among the 11 cases of HGPIN, 6 were seen in association
with BPH, 3 were along with BPH and prostatitis while 2 had
no other pathology. Among the 6 cases of LGPIN, 4 were seen
in association with BPH, while 2 had no other pathology.
The age wise distribution of the prostate lesions has been
shown in Table 2. Statistically there was no difference in the
occurrence of the lesions in varied age groups (p>0.05).
The primary resident missed 4 cases of HGPIN and 2 cases
of LGPIN. Interobserver agreement between the resident and
senior pathologist was fair (Kappa 0.282, p value=0.335)
4. Discussion
The continuous research about PIN has shifted the man-
agement of PCa from surgical treatment towards surveil-
lance(20). The study results show the prostate lesions re-
mains silent and is not detected up to the late fifties. The
exact causation of the lesion is not yet known and hence it
is important to detect its occurrence as early as possible, to
reduce mortality and morbidity. Hence overall the study of
prevalence of benign and premalignant changes in prostate,
that is PIN, becomes important.
The considerate attention has been paid to the prostate le-
sions especially PIN because it forms the link of continuum
from normal prostate to PCa. Since it seldom increases size
of the prostate or PSA levels, its detection relies solely on
the biopsy. As against the reported incidence of 4-16% of
PIN(21), we report a prevalence of 15.4% PIN. The signifi-
cance lies in the fact that it demands repeated biopsies to see
the progress and risk of PCa over the next 10 years(21). In
our case, that was not feasible since we included the prostate
specimens of the cadavers, but it provided us the opportunity
to biopsy the whole of the prostate even to the minor sections
to see the presence of PCa(22, 23). With PIN showing high-
grade changes in BPH cases, however even after re-sampling
from various other areas of the gland, there was no evidence
of malignancy in the present study.
The prevalence of HGPIN was minimum in the 5th decade,
and increased progressively thereafter though it failed to
reach a statistical significance (p>0.05). This is in accordance
with the literature Davidson et al.(22), which states that the
process of dysplastic changes may start at third decade of age
with increasing incidence with advancing age. We observed
that 11 cases out of 110 showed changes of HGPIN (preva-
lence rate of 10%) and 06 cases showed changes of LGPIN
(prevalence rate of 5.4%). Majority of the cases of LGPIN
were seen in 41-50 year age group compared to HGPIN which
was seen maximally in older age groups - i.e., 6th decade on-
wards. It was found that prevalence of LGPIN declined after
the 5th decade and no case of LGPIN was seen among the
specimens from the 71-80 age group. This is in contrast to
the observations of McNeal JE et al.(24), who described simi-
lar age distribution for both LGPIN and HGPIN. The findings
of our study therefore indicate that with advancing age the
changes of low grade PIN progressed to high grade group in
general population.
Interestingly we found that PIN lesions were more associated
with BPH (fibromuscular or glandular hyperplasia) or pro-
statitis (chronic inflammation) and not simultaneous PCa.
This correlates with the previous studies(23, 25, 26). The
lesions of PIN showed histopathologic characteristics inter-
mediate between normal prostate and PCa including loss
of normal architecture, cell differentiation, stratification and
nuclear changes. The architectural patterns has been de-
scribed in the literature(27, 28). Two cases showed the clas-
sical micropapillary pattern. In addition, one of them show-
ing the presence of epithelial trabecular bars with epithelial
structures traversing glandular lumen and inserted into op-
posite wall. While in nine cases typical tufting pattern was
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shown. These findings correlate well with studies by Bost-
wick et al(29). Special stains were done on two cases among
which PAS was used to delineate basement membrane where
difficulty was encountered in ruling out stromal invasion on
routine H&E.
Surprisingly, there was a single case of carcinoma of prostate
which was present in more advanced age (71-80 years). This
shows that men in eighties can have latent PCa which may
not present itself with symptoms. It concurs with the fact
that men over 50 can have a latent prostate disease which
may progressively develop into PCa(30). The targets of the
continuing research have been to innovate newer therapeu-
tics to intervene in the cycle and prevent the neoplastic dis-
ease progression. “Androgen deprivation therapy” has shown
good results to decreases the prevalence PIN, indicating that
it may play an effective role in prevention (29).
4.1. Interobserver variability
From the overall diagnostic point of view, the current three
tier system for PIN24 holds inconsistency in reporting among
various pathologists (based on years of experience) and
uropathologists; based on which it was converted to two a
two tier system(31). Though there are theoretical differences
in terms of nuclear morphology, nucleoli, and basal cell dis-
ruption, the distinction can be erroneous because of certain
mimics such as metaplasia, PCa and overt benign prolifera-
tions(17, 18, 32-34).
Despite this, there exists interobserver variability while diag-
nosing and reporting PIN. It poses a concern for the progno-
sis of the patients. The primary reporting pathologist missed
6 cases of PIN and diagnosed them as normal prostate or PCa
among which 2 were LGPIN and 4 were HGPIN. Among other
studies missing of HGPIN was 75% in Tan et al. (35), 45% in
Aldaoud N et al.(13), and 34.5% by Kronz et al(19).
Overall, the Kappa agreement in the present study was just
fair (Kappa 0.282, p value=0.335) as opposed to the study of
Aldaoud N et al.(13), where among the 65 cases of HGPIN, the
lesion was correctly recognized in 36 (55%) cases and missed
in 29 (45%) cases. (Kappa 0.53, p value>0.05) The causes of
variation include the section of slide examined, the unfamil-
iarity in mind of all the different permutations and combina-
tions and the continuously changing reporting system. Dif-
ferent approaches such as consultation with a uropatholo-
gist, examination of multiple sections, special stains and use
of molecular markers such as ETV4(36) have come into play
for a better differentiation. Besides, there has been a chang-
ing terminology in concordance with Gleason grading where
florid HGPIN are labelled as intraductal cancer (IDC). Due
to the marginal risk of PCa with HGPIN, the term is being
thought to be omitted(37).
The results of the present study hold importance in terms
of providing the prevalence of the prostate lesions in the
healthy population. The results may be validated in the fu-
ture studies on a larger sample size to gain more insight into
the prostate changes with age.
The study results must be interpreted in view of certain limi-
tations. Firstly, the interobserver variability was between two
pathologists with a difference in the experience and not be-
tween a pathologist and uropathologist. Second, PSA levels
were not obtained from the cohort. Third, as this study was
done on cadavers, the relevant data about the patients was
restricted only to age as there was no one to provide the ad-
ditional data of the patients and this can be a source of po-
tential bias. Lastly, the age distribution in this study mostly
included the middle age range and older people were less.
Therefore, there might be an age bias in the reporting of the
data.
5. Conclusion
We report a high prevalence of BPH and PIN lesions in
healthy prostate though the cadaver autopsies. There was a
fair agreement between the resident and senior pathologist
in diagnosing the PIN lesions.
In conclusion, prostate lesions remain latent and show high
prevalence in general population without causing any symp-
toms. The microscopic presence of HGPIN from as early
as fifth decade prompts us to recommend regular prostate
screening programs to make the general population aware
about it. The consultation with senior pathologists seems
to be a better option while reaching a final diagnosis for
prostate lesions.
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Table 1: Prevalence of Prostatic Lesions (n= 110).
Lesion n (%) 95% C)
Normal 8(7.27%) 2.34% - 12.20%
BPH 72(65.4%) 56% - 73.9%
HGPIN 11(10%) 4.3% - 15.6%
LGPIN 6(5.4%) 1.1% – 9.6%
Prostatitis 12(10.9%) 5% - 16.7%
Malignancy 1(0.9%) 0% - 2.71%
Table 2: Prevalence of various prostatic lesions with respect to age (n = 110).
Age (years) Total Cases Normal BPH HGPIN LGPIN Prostatitis Malignancy P value Test
41-50 38 4 25 2 3 4 Nil 0.675
51-60 38 2 26 4 2 4 Nil 0.996 Fisher’s Exact test
61-70 20 0 13 3 1 3 Nil 0.664
71-80 14 2 8 2 Nil 1 1 0.165
Total 110 8 72 11 6 12 1
P value 0.266 0.901 0.557 0.935 0.917 0.127
Test Fisher Fisher Fisher Fisher
performed Exact X² test Exact Exact Exact
test test test test
Mean ± SD 52.64 ± 8.32
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